Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 19/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7310384 | 0.95 | ITGB3 (0.48) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7344174 | 0.92 | ITGB3 (0.47) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7308092 | 0.90 | ITGB3 (0.44) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7317424 | 0.90 | ITGB3 (0.45) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7318763 | 0.87 | ITGB3 (0.43) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7314483 | 0.87 | ITGB3 (0.47) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7304501 | 0.85 | ITGB3 (0.45) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7636198 | 0.84 | ITGB3 (0.45) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7633200 | 0.82 | ITGB3 (0.43) | ITGB3ITGA2BSIGMAR1 | |
| SCHEMBL7316965 | 0.82 | ITGB3 (0.44) | ITGB3ITGA2BSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455529-B1 | OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-09-24 | — | — | US | disclosed |
| EP-0741133-A2 | Adhesion receptor antagonists | MERCK PATENT GmbH (DE) | 1996-11-06 | — | — | EP | disclosed |